Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Expert Opinion on Biological Therapy|April 17, 2013
Hematopoietic progenitor cells transplantation for recurrent or refractory Hodgkin's lymphomaTiziana Moscato, Roberta Fedele, Giuseppe Messina, et al.Expert Opinion on Biological Therapy|December 15, 2015
Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agentsMassimo Martino, Moreno Festuccia, Roberta Fedele, et al.European Journal of Haematology|August 26, 2006
Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patientsMassimo Martino, Giulia Praticò, Giuseppe Messina, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Bone marrow failure associated with herpesvirus 8 infection in a patient undergoing autologous peripheral blood stem cell transplantationMaria Cuzzola, Giuseppe Irrera, Olga Iacopino, et al.European Journal of Haematology|October 18, 2006
Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patientsMassimo Martino, Giuseppe Console, Vincenzo Callea, et al.Clinical Lymphoma, Myeloma & Leukemia|June 26, 2017
Autologous Stem Cell Transplantation in Patients With Multiple Myeloma: An Activity-based Costing Analysis, Comparing a Total Inpatient Model Versus an Early Discharge ModelMassimo Martino, Giuseppe Console, Letteria Russo, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2015
Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor ageMassimo Martino, Erminio Bonizzoni, Tiziana Moscato, et al.Haematologica|April 12, 2012
A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host diseaseMaria Cuzzola, Maurizio Fiasché, Pasquale Iacopino, et al.Journal of Clinical Apheresis|March 15, 2006
Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF)Massimo Martino, Ida Callea, Antonia Condemi, et al.Tumori|June 15, 2007
Wernicke's encephalopathy after allogeneic stem cell transplantationGiuseppe Messina, Eugenia Quartarone, Giuseppe Console, et al.Pageof 4